Related references
Note: Only part of the references are listed.Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin
Filipe Elvas et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Noninvasive Molecular Imaging of Apoptosis in a Mouse Model of Anthracycline-Induced Cardiotoxicity
Helen Su et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2015)
Characterization of [99mTc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
Filipe Elvas et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Imaging Caspase-3 Activation as a Marker of Apoptosis-Targeted Treatment Response in Cancer
Delphine L. Chen et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
A Peptide-Based Positron Emission Tomography Probe for In Vivo Detection of Caspase Activity in Apoptotic Cells
Matthew R. Hight et al.
CLINICAL CANCER RESEARCH (2014)
In vivo evaluation of 18F-labeled TCO for pre-targeted PET imaging in the brain
Leonie Wyffels et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Preclinical Assessment of Carboplatin Treatment Efficacy in Lung Cancer by 18F-ICMT-11-Positron Emission Tomography
Timothy H. Witney et al.
PLOS ONE (2014)
Temporal and Spatial Evolution of Therapy-Induced Tumor Apoptosis Detected by Caspase-3-Selective Molecular Imaging
Quang-De Nguyen et al.
CLINICAL CANCER RESEARCH (2013)
Biodistribution and Radiation Dosimetry of 18F-CP-18, a Potential Apoptosis Imaging Agent, as Determined from PET/CT Scans in Healthy Volunteers
Mohan Doss et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Evaluation of [18F]-CP18 as a PET Imaging Tracer for Apoptosis
Helen Su et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
In Vitro and In Vivo Evaluation of the Caspase-3 Substrate-Based Radiotracer [18F]-CP18 for PET Imaging of Apoptosis in Tumors
Chun-Fang Xia et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
A single-step kit formulation for the 99mTc-labeling of HYNIC-Duramycin
Ming Zhao et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Secondary necrosis: The natural outcome of the complete apoptotic program
Manuel T. Silva
FEBS LETTERS (2010)
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells
Christel Vangestel et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide
Quang-De Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Monitoring of Treatment-Induced Apoptosis in Oncology with PET and SPECT
Francis G. Blankenberg
CURRENT PHARMACEUTICAL DESIGN (2008)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Clearance of apoptotic and necrotic cells and its immunological consequences
Dmitri V. Krysko et al.
APOPTOSIS (2006)
Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts
RG Azrak et al.
CLINICAL CANCER RESEARCH (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Evaluation of thymidylate synthase protein expression by Western blotting and immunohistochemistry on human colon carcinoma xenografts in nude mice
M Derenzini et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Visualization of cell death in vivo with the annexin A5 imaging protocol
CPM Reutelingsperger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Irinotecan (CPT-11): Recent developments and future directions-colorectal cancer and beyond
ML Rothenberg
ONCOLOGIST (2001)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
